Efficacy of continuous erythropoietin receptor activator for end-stage renal disease patients with renal anemia before and after peritoneal dialysis initiation

BACKGROUND: Serial management of renal anemia using continuous erythropoietin receptor activator (CERA) throughout the peritoneal dialysis initiation period has rarely been reported. We investigated the efficacy and dosage of CERA treatment from pre- to post-peritoneal dialysis initiation for anemia...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujimoto, Daisuke, Adachi, Masataka, Miyasato, Yoshikazu, Hata, Yusuke, Inoue, Hideki, Oda, Akira, Kakizoe, Yutaka, Nakagawa, Terumasa, Shimasaki, Akiko, Nakamura, Keishi, Nagayoshi, Yu, Mukoyama, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880977/
https://www.ncbi.nlm.nih.gov/pubmed/33025233
http://dx.doi.org/10.1007/s10157-020-01973-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880977/
https://www.ncbi.nlm.nih.gov/pubmed/33025233
http://dx.doi.org/10.1007/s10157-020-01973-x

Ejemplares similares